Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Syndax Pharmaceuticals Inc (SNDX)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 3
  • 1 comments

Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

ADMA Biologics Inc (ADMA)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 3
  • 1 comments

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

Market reaction Comment Full text

Bausch Health Companies Inc (BHC)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 5
  • 1 comments

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Olema Oncology (OLMA)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 2
  • 1 comments

Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Agios Pharmaceuticals Inc (AGIO)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 3
  • 1 comments

Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Market reaction Comment Full text

Tango Therapeutics Inc. (TNGX)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 3
  • 1 comments

Tango Therapeutics Appoints Sung Lee to Board of Directors

Market reaction Comment Full text

Rocket Pharmaceuticals Inc (RCKT)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 3
  • 1 comments

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Dianthus Therapeutics Inc (DNTH)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 2
  • 1 comments

Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Marker Therapeutics Inc. (MRKR)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 4
  • 1 comments

Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer

Market reaction Comment Full text

Protalix BioTherapeutics Inc. (PLX)

  • Business News
  • Jan. 05, 2026, 11:50 UTC
  • 0
  • 1 comments

Protalix BioTherapeutics Letter to Stockholders

Market reaction Comment Full text
  • Previous
  • 183
  • 184
  • 185
  • 186
  • 187
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2252)
  • SEC News(189201)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124560)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin